Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Andrea Hrustincova"'
Autor:
Iva Trsova, Andrea Hrustincova, Zdenek Krejcik, David Kundrat, Aleš Holoubek, Karolina Staflova, Lucie Janstova, Sarka Vanikova, Katarina Szikszai, Jiri Klema, Petr Rysavy, Monika Belickova, Monika Kaisrlikova, Jitka Vesela, Jaroslav Cermak, Anna Jonasova, Jiri Dostal, Jan Fric, Jan Musil, Michaela Dostalova Merkerova
Publikováno v:
Molecular Oncology, Vol 17, Iss 12, Pp 2565-2583 (2023)
Mutations in the splicing factor 3b subunit 1 (SF3B1) gene are frequent in myelodysplastic neoplasms (MDS). Because the splicing process is involved in the production of circular RNAs (circRNAs), we investigated the impact of SF3B1 mutations on circR
Externí odkaz:
https://doaj.org/article/cf124e1e1eda474f8d617a5629fc916b
Autor:
Andrea Hrustincova, Zdenek Krejcik, David Kundrat, Katarina Szikszai, Monika Belickova, Pavla Pecherkova, Jiri Klema, Jitka Vesela, Monika Hruba, Jaroslav Cermak, Tereza Hrdinova, Matyas Krijt, Jan Valka, Anna Jonasova, Michaela Dostalova Merkerova
Publikováno v:
Cells, Vol 9, Iss 4, p 794 (2020)
Myelodysplastic syndromes (MDS) are hematopoietic stem cell disorders with large heterogeneity at the clinical and molecular levels. As diagnostic procedures shift from bone marrow biopsies towards less invasive techniques, circulating small noncodin
Externí odkaz:
https://doaj.org/article/6694200bbc214c129172b7000b61d9f9
Autor:
Michaela Dostalova Merkerova, Hana Remesova, Zdenek Krejcik, Nikoleta Loudova, Andrea Hrustincova, Katarina Szikszai, Jaroslav Cermak, Anna Jonasova, Monika Belickova
Publikováno v:
Cells, Vol 7, Iss 9, p 138 (2018)
The DLK1–DIO3 region contains a large miRNA cluster, the overexpression of which has previously been associated with myelodysplastic syndromes (MDS). To reveal whether this overexpression is epigenetically regulated, we performed an integrative ana
Externí odkaz:
https://doaj.org/article/db4f5dfe21ed4b1bbfe2ccc30bd0d202
Autor:
Michaela Dostalova, Merkerova, Jiri, Klema, David, Kundrat, Katarina, Szikszai, Zdenek, Krejcik, Andrea, Hrustincova, Iva, Trsova, Anh Vu, LE, Jaroslav, Cermak, Anna, Jonasova, Monika, Belickova
Publikováno v:
Cancer Genomics Proteomics
Background/Aim: Prediction of response to azacitidine (AZA) treatment is an important challenge in hematooncology. In addition to protein coding genes (PCGs), AZA efficiency is influenced by various noncoding RNAs (ncRNAs), including long ncRNAs (lnc
Autor:
Iva Trsová, Monika Belickova, Andrea Hrustincova, Monika Kaisrlikova, Zuzana Lenertova, David Kundrat, Zdenek Krejcik, Jitka Vesela, Jiri Klema, Petr Ryšavý, Jaroslav Cermak, Michaela Dostalova Merkerova
Publikováno v:
Blood. 140:4005-4006
Autor:
Viktor Stranecky, Jaroslav Cermak, Nikoleta Loudova, Anna Jonasova, Monika Belickova, Michaela Dostalova Merkerova, Jiri Klema, Zdenek Krejcik, Katarina Szikszai, David Kundrat, Jitka Vesela, Pavla Pecherkova, Monika Hruba, Andrea Hrustincova
Publikováno v:
Cancers
Volume 12
Issue 10
Cancers, Vol 12, Iss 2726, p 2726 (2020)
Volume 12
Issue 10
Cancers, Vol 12, Iss 2726, p 2726 (2020)
Simple Summary Although lncRNAs have been increasingly recognized as regulators of hematopoiesis, only several studies addressed their role in myelodysplastic syndrome (MDS). By genome-wide profiling, we identified lncRNAs deregulated in various grou
Autor:
Monika Belickova, Anna Jonasova, Zdenek Krejcik, Jaroslav Cermak, Jan E. Dyr, Andrea Hrustincova, Michaela Dostalova Merkerova, Hana Votavova
Publikováno v:
Cancer Biomarkers. 22:101-110
Background Azacitidine (AZA) is a nucleoside analog used for treatment of myelodysplasia and the prediction of AZA responsiveness is important for the therapy management. Methods Using microarrays and reverse-transcription quantitative-PCR, we analyz
Autor:
Jiri Klema, Katarina Szikszai, Andrea Hrustincova, Zdenek Krejcik, Monika Belickova, Iva Trsova, Michaela Dostalova Merkerova, David Kundrat, Jaroslav Cermak, Jitka Vesela, Monika Kaisrlikova
Publikováno v:
Blood. 138:2590-2590
Myelodysplastic syndromes (MDS) are a heterogeneous group of diseases with a high risk of transformation to acute myeloid leukemia (AML). One of the processes implicated in MDS pathogenesis is RNA splicing. Its alterations are caused by somatic mutat
Autor:
Matyas Krijt, Jaroslav Cermak, Pavla Pecherkova, Jan Valka, Tereza Hrdinova, Jitka Vesela, Jiri Klema, Anna Jonasova, Zdenek Krejcik, Katarina Szikszai, Michaela Dostalova Merkerova, Monika Belickova, Monika Hruba, David Kundrat, Andrea Hrustincova
Publikováno v:
Cells, Vol 9, Iss 4, p 794 (2020)
Cells
Volume 9
Issue 4
Cells
Volume 9
Issue 4
Myelodysplastic syndromes (MDS) are hematopoietic stem cell disorders with large heterogeneity at the clinical and molecular levels. As diagnostic procedures shift from bone marrow biopsies towards less invasive techniques, circulating small noncodin